Skip NavigationSkip to Content
Return Return to Search Results

Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549

  1. Author:
    Sithanandam, G.
    Fornwald, L. W.
    Fields, J.
    Anderson, L. M.

  2. Author Address

    NCI, SAIC Frederick, Basic Res Program, Frederick, MD 21702 USA. NCI, Comparat Carcinogenesis Lab, Ft Detrick, MD 21702 USA Sithanandam, G, NCI, SAIC Frederick, Basic Res Program, Frederick, MD 21702 USA
    1. Year: 2005
    2. Date: MAR 10
  2. Journal: Oncogene
    1. 24
    2. 11
    3. Pages: 1847-1859
  4. Type of Article: Article
  1. Abstract:

    The ErbB3 receptor and the downstream signaling kinase Akt are implicated in proliferation of lung adenocarcinoma cells. Inhibition by siRNAs to ErbB3 and Akt isoforms 1, 2 and 3 was utilized to investigate the contribution of these molecules to tumor survival, spreading and invasiveness, and the roles of specific Akt isoforms. ErbB3 siRNA stably and dose-dependently suppressed ErbB3 protein for 2 days or more, and reduced cell numbers, by both suppressing cell cycle and causing apoptosis and necrosis. It also inhibited soft agar growth, cell motility and migration, and invasiveness. Akt1, 2 and 3 siRNAs had similar suppressive effects on cell number, apoptosis/ necrosis and soft agar growth. However, although Akt1 siRNA had no effect on cell migration or invasion, Akt2 siRNA effectively suppressed both activities, and Akt3 siRNA had moderate effectiveness. In A549 cells, ErbB3 is indicated as having major effects on cell division, survival, motility, migration and invasiveness. All three Akt isoforms are to varying degrees involved in these cell behaviors, with Akt2 especially implicated in migration and invasion. ErbB3 and the Akts are promising targets for therapy, and siRNAs may be useful for this purpose

    See More

  1. Keywords:

External Sources

  1. View record in Web of Science®
  2. WOS: 000227542000004

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel